HCAT
NASDAQHealth Catalyst Inc
Price$1.73-0.55 (-24.12%)
2026-07-162026-10-16
News · 26 weeks53-87%
2026-04-192026-10-11
Mix2890d
- Insider13(46%)
- SEC Filings6(21%)
- Other4(14%)
- Earnings2(7%)
- Leadership2(7%)
- Analyst1(4%)
Latest news
25 items- INSIDERSEC Form 4 filed by Health Catalyst Inc4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERSEC Form 3 filed by Health Catalyst Inc3 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Executive Officer Kohl Simeon was granted 2,747,385 shares and bought $105,439 worth of shares (59,000 units at $1.79), increasing direct ownership by 5,613% to 2,856,385 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERNew insider Kohl Simeon claimed ownership of 25,000 shares (SEC Form 3)3 - Health Catalyst, Inc. (0001636422) (Issuer)
- PRHealth Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company’s Board of Directors granted 2,747,385 restricted stock units (the "RSUs") to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the "Inducement Plan") in connection with Mr. Kohl’s previously announced appointment as Chief Executive Officer and President of the Company effective on September 14, 2026. The awards were granted as inducement material t
- SECSEC Form S-8 filed by Health Catalyst IncS-8 - Health Catalyst, Inc. (0001636422) (Filer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Strengthens Its Board with the Appointment of Tami RellerReller Joins Health Catalyst as it Enters Its Next Phase of GrowthSALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami Reller has been appointed to its board of directors (Board), effective October 1, 2026. Reller will serve as audit chair and as a member of its compensation committee, also effective October 1, 2026. Reller's appointment follows the naming of Simeon Kohl as Chief Executive Officer and President, effective September 14, 2026. Under K
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 35,244 shares, decreasing direct ownership by 2% to 1,388,406 units (SEC Form 4) to satisfy tax liability4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst IncSCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)
- SECHealth Catalyst Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Appoints Simeon Kohl as Chief Executive Officer and PresidentSALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company’s Board of Directors, effective September 14, 2026. Simeon Kohl most recently served as Chief Executive Officer of Performant Healthcare, a public healthcare company he led through a period of significant strategic and operational transformation, culminating in its successful sale to Machinify for approximately $670 million. He brings more than 20
- INSIDERDirector Larson-Green Julie was granted 9,766 shares, increasing direct ownership by 6% to 185,101 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 321 shares, decreasing direct ownership by 0.02% to 1,423,650 units (SEC Form 4) (tax liability)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Financial Officer Alger Jason covered exercise/tax liability with 17,973 shares, decreasing direct ownership by 2% to 704,867 units (SEC Form 4) to cover withholding tax4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERGeneral Counsel Landry Benjamin covered exercise/tax liability with 13,167 shares, decreasing direct ownership by 4% to 351,372 units (SEC Form 4) (tax withholding)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- PRHealth Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026. About Health Catalyst Health Catalyst, Inc. (NASDAQ:HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $
- ANALYSTHealth Catalyst downgraded by Canaccord Genuity with a new price targetCanaccord Genuity downgraded Health Catalyst from Buy to Hold and set a new price target of $1.80
- SECSEC Form 10-Q filed by Health Catalyst Inc10-Q - Health Catalyst, Inc. (0001636422) (Filer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence CompanyCompany retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance.SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026. Having used the net cash proceeds plus cash on hand to fully repay and terminate all of its obligations under its credit facility, Healt
- PRHealth Catalyst Reports Second Quarter 2026 ResultsSALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. "We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, we recently closed the Vitalware divestiture and fully repaid our credit facility debt, which significantly improves our balance sheet and provides flexibility to make measured near-term bets i
- PRHealth Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-274-8461 for U.S. participants, or 203-518-9814 for international participants, and referencing conference ID "HCATQ226." A live audio webcast will be available online at https://ir.healthcatalyst.com/
- INSIDERDirector Hoggard Green Jill was granted 80,691 shares, increasing direct ownership by 126% to 144,628 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Larson-Green Julie was granted 80,691 shares, increasing direct ownership by 85% to 175,335 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
HCAT FAQ
7 questionsWhat does Health Catalyst Inc do?
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.Where does HCAT stock trade?
Health Catalyst Inc (HCAT) is listed on NASDAQ.What sector and industry is HCAT in?
Health Catalyst Inc operates in the Technology sector, Computer Software: Programming Data Processing industry.When did Health Catalyst Inc go public?
Health Catalyst Inc (HCAT) completed its IPO in 2019.What are analysts saying about HCAT?
Health Catalyst Inc has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Hold with a $180.00 price target on 2026-08-21.What companies are similar to HCAT?
Notable peers in the same industry include GOOGL (Alphabet Inc.), GOOG (Alphabet Inc.), META (Meta Platforms Inc.), APP (Applovin Corporation), NBIS (Nebius Group N.V.). Compare HCAT side-by-side with any of them on Quantisnow.How can I track HCAT on Quantisnow?
Quantisnow aggregates Health Catalyst Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HCAT to receive live email and push alerts on every new disclosure.